Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.95%31.83M | -1.68%34.05M | -0.56%36.65M | 6.64%143.96M | 37.12M | 35.35M | 34.64M | 36.86M | 10.03%134.99M | 21.67%122.69M |
| Cost of revenue | -12.77%27.56M | -6.68%29.51M | 2.81%32.27M | 10.73%128.16M | 33.56M | 31.59M | 31.62M | 31.39M | 12.04%115.73M | 19.21%103.29M |
| Gross profit | 13.73%4.27M | 50.65%4.55M | -19.91%4.38M | -17.93%15.81M | 3.57M | 3.76M | 3.02M | 5.46M | -0.68%19.26M | 36.74%19.39M |
| Operating expense | 10.62%2.96M | -41.97%3.26M | 2.39%3.13M | 68.64%15.12M | 3.59M | 2.68M | 5.62M | 3.05M | 4.23%8.96M | 15.05%8.6M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.41%3.88M | 6.67%3.82M |
| Selling and administrative expenses | 10.62%2.96M | -41.97%3.26M | 5.75%3.26M | 68.64%15.12M | --3.59M | --2.68M | --5.62M | --3.08M | 110.91%8.96M | 24.74%4.25M |
| -Selling and marketing expense | ---- | ---- | ---- | 31.30%4.51M | ---- | ---- | ---- | ---- | 3.51%3.43M | 22.36%3.32M |
| -General and administrative expense | 10.62%2.96M | -41.97%3.26M | 5.75%3.26M | 91.81%10.61M | --3.59M | --2.68M | --5.62M | --3.08M | 492.21%5.53M | 34.00%934K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.15%380K | 9.41%372K |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.15%380K | 9.41%372K |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.59%88K | 8.89%49K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -19.44%87K | 6.93%108K |
| Total other operating income | ---- | ---- | 416.00%129K | ---- | ---- | ---- | ---- | --25K | ---- | ---- |
| Operating profit | 21.44%1.31M | 149.63%1.29M | -48.17%1.25M | -93.31%689.01K | -26K | 1.08M | -2.6M | 2.41M | -4.60%10.29M | 60.92%10.79M |
| Net non-operating interest income (expenses) | 26.77%-197K | 33.67%-262K | 30.02%-289K | 12.01%-1.27M | -231K | -269K | -395K | -413K | -21.70%-1.44M | -23.67%-1.19M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 28.95%98K | 117.14%76K |
| Non-operating interest expense | -26.77%197K | -33.67%262K | -30.02%289K | -12.01%1.27M | --231K | --269K | --395K | --413K | 22.42%1.44M | 27.74%1.18M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.43%90K | 16.90%83K |
| Net investment income | -404.17%-73K | 2,500.00%24K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -285.71%-27K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | -97.22%2K | 700.00%72K | ||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 46.91%-43K | -47.27%-81K |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- | -122.22%-2K | -86.57%9K |
| Other non-operating income (expenses) | 16.03%181K | 815.00%183K | 416.00%129K | 241.12%682.04K | 365K | 156K | 20K | 25K | 227.77%199.94K | -23.75%61K |
| Income before tax | 33.95%1.3M | 140.71%1.21M | -51.93%960K | -98.88%101.06K | 108K | 969K | -2.97M | 2M | -7.00%9.05M | 67.64%9.74M |
| Income tax | 1.36%223K | 395.59%337K | -43.00%281K | -63.89%820.32K | 40K | 220K | 68K | 493K | -13.23%2.27M | 71.67%2.62M |
| Net income | 43.52%1.08M | 128.72%873K | -54.85%679K | -110.61%-719.26K | 68K | 749K | -3.04M | 1.5M | -4.71%6.78M | 66.21%7.12M |
| Net income continuous operations | 43.52%1.08M | 128.72%873K | -54.85%679K | -110.61%-719.26K | --68K | --749K | ---3.04M | --1.5M | -4.71%6.78M | 66.21%7.12M |
| Noncontrolling interests | 0 | 0 | ||||||||
| Net income attributable to the company | 43.52%1.08M | 128.72%873K | -54.85%679K | -110.61%-719.26K | 68K | 749K | -3.04M | 1.5M | -4.71%6.78M | 66.21%7.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 43.52%1.08M | 128.72%873K | -54.85%679K | -110.61%-719.26K | 68K | 749K | -3.04M | 1.5M | -4.71%6.78M | 66.21%7.12M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 43.24%0.0053 | 128.67%0.0043 | -55.50%0.0033 | -111.96%-0.004 | 0 | 0.0037 | -0.015 | 0.0074 | -4.71%0.0334 | 66.21%0.0351 |
| Diluted earnings per share | 43.24%0.0053 | 128.67%0.0043 | -55.50%0.0033 | -111.96%-0.004 | 0 | 0.0037 | -0.015 | 0.0074 | -4.71%0.0334 | 66.21%0.0351 |
| Dividend per share | 0.01 | |||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.